(Q40679085)
Statements
1 reference
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer (English)
1 reference
Angevin E
1 reference
Valteau-Couanet D
1 reference
Farace F
1 reference
Dietrich PY
1 reference
Lecesne A
1 reference
Triebel F
1 reference
Escudier B
1 reference
1 October 1995
1 reference
1 reference
18
1 reference
3
1 reference
188-195
1 reference
Identifiers
1 reference